Stay updated with breaking news from Jonathanr Genzen. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
A proposed rule that would change FDA oversight of laboratory-developed tests may have negative effects on cancer care and innovation in oncology, according to critics. A proposed rule that would change FDA oversight of laboratory-developed tests may have negative effects on cancer care and innovation in oncology.
A proposed rule that would change FDA oversight of laboratory-developed tests may have negative effects on cancer care and innovation in oncology, according to critics. A proposed rule that would change FDA oversight of laboratory-developed tests may have negative effects on cancer care and innovation in oncology.
/PRNewswire/ -- A new survey from the Association for Diagnostics & Laboratory Medicine (formerly AACC) found that clinical labs' robust, rapid response to the...